Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

PepGen Inc. Common Stock (PEPG)

Pharmaceutical Preparations

https://www.pepgen.com

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

1 MARINA PARK DRIVE, SUITE 900
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/06/2022

Market Cap

303,410,135

Shares Outstanding

23,810,000

Weighted SO

23,813,547

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.7360

Last Div

0.0000

Range

3.72-19.298

Chg

0.2400

Avg Vol

163801

Mkt Cap

303410135

Exch

NASDAQ

Country

US

Phone

781-797-0979

DCF Diff

6.8154

DCF

2.5496

Div Yield

0.0000

P/S

182.7772

EV Multiple

-2.7179

P/FV

1.9497

Div Yield %

0.0000

P/E

-3.3912

PEG

0.2530

Payout

0.0000

Current Ratio

7.4537

Quick Ratio

7.4537

Cash Ratio

2.9893

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1949.9413

CCC

-1949.9413

Gross Margin

0.1271

Op Margin

-57.7193

Pretax Margin

-53.6548

Net Margin

-53.6988

Eff Tax Rate

0.0132

ROA

-0.4606

ROE

-0.6274

ROCE

-0.5590

NI/EBT

1.0008

EBT/EBIT

0.9296

EBIT/Rev

-57.7193

Debt Ratio

0.1003

D/E

0.1252

LT Debt/Cap

0.0955

Total Debt/Cap

0.1113

Int Coverage

-50.4550

CF/Debt

-3.8525

Equity Multi

1.2481

Rec Turnover

0.0000

Pay Turnover

0.1872

Inv Turnover

0.0000

FA Turnover

0.0620

Asset Turnover

0.0086

OCF/Share

-2.3033

FCF/Share

-2.3184

Cash/Share

4.9680

OCF/Sales

-45.0512

FCF/OCF

1.0066

CF Coverage

-3.8525

ST Coverage

-24.5277

CapEx Coverage

-151.6937

Div&CapEx Cov

-151.6937

P/BV

1.9497

P/B

1.9497

P/S

182.7772

P/E

-3.3912

P/FCF

-4.0305

P/OCF

-4.0421

P/CF

-4.0421

PEG

0.2530

P/S

182.7772

EV Multiple

-2.7179

P/FV

1.9497

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 24, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, and Tempus and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 21, 15:34 ROSEN, NATIONAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG GlobeNewswire Inc. Jun 18, 22:30 TOP RANKED ROSEN LAW FIRM Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG GlobeNewswire Inc. Jun 17, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, Tempus, and Rocket and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 14, 17:47 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG GlobeNewswire Inc. Jun 12, 01:00 PEPGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against PepGen, Inc. and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 11, 23:29 ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG GlobeNewswire Inc. Apr 25, 20:54 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX

Revenue Product Segmentation